Abstract |
The diagnosis of neurocysticercosis (NCC) depends on neuroimaging and serological confirmation. While antibody detection by enzyme-linked immunoelectrotransfer blot (EITB) fails to predict viable NCC, EITB banding patterns provide information about the host's infection course. Adding antigen enzyme-linked immunosorbent assay (Ag-ELISA) results to EITB banding patterns may improve their ability to predict or rule out of viable NCC. We assessed whether combining EITB banding patterns with Ag-ELISA improves discrimination of viable infection in imaging-confirmed parenchymal NCC. EITB banding patterns were grouped into classes using latent class analysis. True-positive and false-negative Ag-ELISA results in each class were compared using Fisher's exact test. Four classes were identified: 1, EITB negative or positive to GP50 alone ( GP50 antigen family); 2, positive to GP42-39 and GP24 (T24/42 family), with or without GP50; and 3 and 4, positive to GP50, GP42-39, and GP24 and reacting to bands in the 8-kDa family. Most cases in classes 3 and 4 had viable NCC (82% and 88%, respectively) compared to classes 2 and 1 (53% and 5%, respectively). Adding positive Ag-ELISA results to class 2 predicted all viable NCC cases (22/22 [100%]), whereas 11/40 patients (27.5%) Ag-ELISA negative had viable NCC (P < 0.001). Only 1/4 patients (25%) Ag-ELISA positive in class 1 had viable NCC, whereas 1/36 patients (2.8%) Ag-ELISA negative had viable NCC (P = 0.192). In classes 3 and 4, adding Ag-ELISA was not contributory. Combining Ag-ELISA with EITB banding patterns improves discrimination of viable from nonviable NCC, particularly for class 2 responses. Together, these complement neuroimaging more appropriately for the diagnosis of viable NCC.
|
Authors | Gianfranco Arroyo, Javier A Bustos, Andres G Lescano, Isidro Gonzales, Herbert Saavedra, E Javier Pretell, Yesenia Castillo, Erika Perez, Pierre Dorny, Robert H Gilman, Seth E O'Neal, Armando E Gonzalez, Hector H Garcia, Cysticercosis Working Group in Peru (CWGP) |
Journal | Journal of clinical microbiology
(J Clin Microbiol)
Vol. 60
Issue 2
Pg. e0155021
(02 16 2022)
ISSN: 1098-660X [Electronic] United States |
PMID | 34851685
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Helminth
- Antigens, Helminth
|
Topics |
- Animals
- Antibodies, Helminth
- Antigens, Helminth
- Enzyme-Linked Immunosorbent Assay
(methods)
- Humans
- Neurocysticercosis
(diagnosis)
- Sensitivity and Specificity
- Taenia solium
|